GF-CART01
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for GF-CART01, covering 2025-12-18 to 2025-12-22. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Evaluate the Safety and Clinical Activity of GF- CART01 (CD20/19 CAR T Cell) in Subjects With Relapsed or Refractory B-Cell Hematological Malignancies [Phase 1]